Colombian Navy Ship Open for Free Public Tours in Curaçao

Carmabi, Curaçao's Caribbean Research and Management of Biodiversity foundation, has launched Ocean Guardian Day, a new program inviting participants to actively contribute to local nature restoration efforts. The initiative blends hands-on conservation work with educational components, giving participants a deeper understanding of Curaçao's natural ecosystems. The program integrates nature management and scientific research, making it both a practical and academic experience. Ocean Guardian Day is designed to engage residents and visitors alike in protecting the island's marine and terrestrial environments. The launch reflects growing concern over ecosystem degradation in the Caribbean and positions Carmabi as a leading force in community-driven conservation on the island. By combining citizen participation with scientific methodology, the program aims to generate meaningful environmental data while building a broader culture of environmental stewardship in Curaçao.

Extra Curaçao published its daily news bulletin, the Extra Journaal, on August 3, 2026. The excerpt provided contains no substantive details about the stories covered in the broadcast or written edition. Without access to the full content of the bulletin, it is not possible to summarize the specific news items, individuals involved, or events reported. The Extra Journaal is a regular news product from Extra, one of Curaçao's prominent local media outlets. Readers seeking the full details of this bulletin are advised to consult the original source directly.

Rotterdam's Erasmus MC hospital will begin conducting DNA tests on premature babies in its intensive care unit starting Monday to prevent antibiotic-induced hearing loss. The test is designed to identify whether a baby carries a specific genetic variant that makes them highly susceptible to deafness when treated with the antibiotic gentamicin, a commonly used drug for infections in premature newborns. Gentamicin is effective and widely administered, but in patients with this particular genetic mutation, it can cause permanent hearing damage. By screening babies before treatment, doctors can adjust their approach and use alternative medications where necessary. The initiative represents a significant step forward in personalized neonatal care, potentially sparing a number of children from lifelong hearing impairment. Erasmus MC is among the first hospitals in the Netherlands to implement this type of preventive genetic screening in a neonatal ICU setting.